20 June 2013
Keywords: inspire, starts, phase, ii, trial, rhinitis, drug
Article | 13 May 2002
Inspire Pharmaceuticals has initiated two Phase IIa trials of INS37217in a nasal spray formulation for the treatment of patients ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.